Shapoval OS, Vorontsova LL. Pathogenetic rationale for the use of immunomodulating and systemic enzyme therapy in treatment of nulliparous women with endometrioid ovary tumors. J Educ Health Sport [Internet]. 2015 Jan. 16 [cited 2025 Jun. 28];5(1):75-86. Available from: https://apcz.umk.pl/JEHS/article/view/2483